West Coast Surfs into Second-Quarter 2016 on $1.7 Billion Wave of Pharmaceutical-Biotech Construction Investments

SUGAR LAND--March 31, 2016--Researched by Annette Kreuger for Industrial Info Resources (Sugar Land, Texas)--Along with its success in attracting beach lovers to the mighty Pacific, the U.S. West Coast region is an investment magnet for the Pharmaceutical-Biotech Industry, indeed for all life science sectors. The region, which comprises California, Washington, Oregon, Hawaii and Alaska, is on record to launch $1.7 billion in capital and MRO (maintenance) projects during second-quarter 2016. Within this article: Description of three pharma-bio projects on the West Coast, including one by Gilead Sciences (NASDAQ:GILD).